Rgl2 - ral guanine nucleotide dissociation stimulator-like 2 Gene
Also Known as Rlf; Rgt2; KE1.5; Rab2l
Species: Mus musculus
Gene Type: protein coding
Gene ID: 19732
Summary
Enables guanyl-nucleotide exchange factor activity. Acts upstream of or within negative regulation of cardiac muscle cell apoptotic process; positive regulation of phosphatidylinositol 3-kinase signaling; and regulation of Ral protein signal transduction. Is expressed in several structures, including alimentary system; genitourinary system; hemolymphoid system gland; integumental system; and nervous system. Orthologous to human RGL2 (ral guanine nucleotide dissociation stimulator like 2). [provided by Alliance of Genome Resources, Apr 2022]
Rgl2 Products (6)
| mRNA | Protein | Name |
|---|---|---|
| NM_001410640.1 | NP_001397569.1 | ral guanine nucleotide dissociation stimulator-like 2 isoform 2 |
| NM_001410641.1 | NP_001397570.1 | ral guanine nucleotide dissociation stimulator-like 2 isoform 3 |
| NM_001410645.1 | NP_001397574.1 | ral guanine nucleotide dissociation stimulator-like 2 isoform 4 |
| NM_001410646.1 | NP_001397575.1 | ral guanine nucleotide dissociation stimulator-like 2 isoform 4 |
| NM_001410647.1 | NP_001397576.1 | ral guanine nucleotide dissociation stimulator-like 2 isoform 4 |
| NM_009059.3 | NP_033085.2 | ral guanine nucleotide dissociation stimulator-like 2 isoform 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
ral guanine nucleotide dissociation stimulator-like 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS11891 | RGL2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21420 | Rgl2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service